# LYBALVI

NDC: 65757-652
Generic name: olanzapine and samidorphan L-malate
Labeler / Manufacturer: Alkermes, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210920

FDA application: NDA213378

## Active ingredients

- OLANZAPINE: 10 mg/1
- SAMIDORPHAN L-MALATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65757-652"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65757-652
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32ffddd1-4e2b-45d9-9b36-bb730167ec80